AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 55,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.

AbbVie, Inc. adalah perusahaan biofarmasi berbasis riset yang terlibat dalam pengembangan dan penjualan produk farmasi. Perusahaan ini berkantor pusat di North Chicago, Illinois dan saat ini mempekerjakan 55.000 karyawan penuh waktu. Perusahaan ini melakukan penawaran umum perdana (IPO) pada 2 Januari 2013. Perusahaan terlibat dalam penelitian dan pengembangan, produksi, komersialisasi, dan penjualan obat-obatan dan terapi. Portofolio produknya mencakup Imunologi, Onkologi, Estetika, Ilmu Saraf, Perawatan Mata, dan Produk Utama Lainnya. Produk Imunologinya mencakup reumatologi, dermatologi, dan gastroenterologi. Produk Onkologinya termasuk Imbruvica, Venclexta/Venclyxto, Elahere, dan Epkinly. Portofolio Estetika Perusahaan terdiri dari injeksi wajah, plastik dan kedokteran regeneratif, kontur tubuh, dan produk perawatan kulit. Produk Ilmu Sarafnya termasuk Botox Terapeutik, Vraylar, Duopa, dan Duodopa, Ubrelvy, dan Qulipta. Produk Perawatan Matanya termasuk Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, dan Perawatan Mata Lainnya. Produk utama lainnya mencakup Mavyret/Maviret, Creon, dan Linzess/Constella. Venclexta adalah penghambat B-cell lymphoma 2 (BCL-2) yang digunakan untuk mengobati kanker darah.

AbbVie Stock

About AbbVie

Key Statistics